Лента новостей - FDA.GOV

  • Novel Drug Approvals for 2019
    Innovation drives progress. When it comes to innovation in the development of new drugs and therapeutic biological products, FDA’s Center for Drug Evaluation and Research (CDER) supports the pharmaceutical industry at every step of the process.
  • What's New Related to Drugs
    Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.
  • MCM-Related Counterterrorism Legislation
    Since September 11, 2001, federal legislation has been enacted to strengthen the nation’s preparedness for responding to public health emergencies involving chemical, biological, radiological, nuclear (CBRN) as well as emerging infectious disease threats.
  • Drug Safety and Risk Management Advisory Committee Roster
    This page contains the DSARM roster, which lists the current members and the current number of vacancies for the committee.
  • Patient Listening Sessions
    Patient Listening Sessions led by FDA’s Patient Affairs Staff provide an opportunity for medical product Centers to engage with patients, caregivers, and their advocates about their experience with a disease or condition.

Проверка уникального кода анализа

Введите код (прописные буквы A-F и цифры 0-9):

Голосование

Какова целевая аудитория нашего сайта. Кто Вы?
 

Лента новостей - http://medpharmconnect.com -Разработка лекарств

Яндекс.Метрика
Яндекс цитирования